• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非传统血脂指标对非肥胖型2型糖尿病患者代谢功能障碍相关脂肪性肝病的预测价值

Non-Traditional Blood Lipid Indices for Metabolism Dysfunction-Associated Fatty Liver Disease Prediction in Non-Obese Type 2 Diabetes Mellitus.

作者信息

Gao Qian, Feng Lei, Zhou Weiling, Li Xiaoli, Yin Lanzi, Wang Yuan

机构信息

Department of Endocrine and Metabolic Diseases, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050000, People's Republic of China.

出版信息

Diabetes Metab Syndr Obes. 2023 Aug 7;16:2345-2354. doi: 10.2147/DMSO.S418020. eCollection 2023.

DOI:10.2147/DMSO.S418020
PMID:37577041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10416783/
Abstract

OBJECTIVE

This study aims to investigate the predictive value of non-traditional blood lipid indices for metabolism dysfunction-associated fatty liver disease (MAFLD) in non-overweight/obese patients with type 2 diabetes mellitus (T2DM).

METHODS

A retrospective observational study was conducted, including non-overweight/obese patients with T2DM who visited the Fourth Hospital of Hebei Medical University between August 2018 and August 2022. The low-density lipoprotein cholesterol (LDL-C)/high-density lipoprotein cholesterol (HDL-C) ratio, the triacylglycerol-glucose index (TyG) multiplied by body mass index (BMI), and TyG/HDL-C ratio were calculated.

RESULTS

The study involved 190 participants, of whom 34 were diagnosed with MAFLD (24 males and 10 females), while 156 did not have MAFLD (64 males and 92 females). Multivariable analysis revealed that aspartate transaminase (AST) (OR=1.216, 95% CI: 1.059-1.374, P=0.006), blood uric acid (BUA) (OR=1.017, 95% CI: 1.002-1.032, P=0.022), TyGBMI (OR=1.231, 95% CI: 1.051-1.442, P=0.010), and TyG/HDL-C (OR=3.162, 95% CI: 1.228-8.141, P=0.017) were independently associated with MAFLD. The TyGBMI index exhibited an area under the ROC curve (AUC) of 0.812, with 91.2% sensitivity and 69.2% specificity for MAFLD. The TyG/HDL-C index had an AUC of 0.929, with 85.3% sensitivity and 88.5% specificity for MAFLD.

CONCLUSION

The results indicate that TyG*BMI and TyG/HDL-C are independently associated with MAFLD in non-overweight/obese patients with T2DM.

摘要

目的

本研究旨在探讨非传统血脂指标对非超重/肥胖2型糖尿病(T2DM)患者代谢功能障碍相关脂肪性肝病(MAFLD)的预测价值。

方法

进行一项回顾性观察研究,纳入2018年8月至2022年8月期间就诊于河北医科大学第四医院的非超重/肥胖T2DM患者。计算低密度脂蛋白胆固醇(LDL-C)/高密度脂蛋白胆固醇(HDL-C)比值、甘油三酯-葡萄糖指数(TyG)乘以体重指数(BMI)以及TyG/HDL-C比值。

结果

该研究纳入190名参与者,其中34例被诊断为MAFLD(男性24例,女性10例),156例未患MAFLD(男性64例,女性92例)。多变量分析显示,天冬氨酸转氨酶(AST)(OR=1.216,95%CI:1.059-1.374,P=0.006)、血尿酸(BUA)(OR=1.017,95%CI:1.002-1.032,P=0.022)、TyGBMI(OR=1.231,95%CI:1.051-1.442,P=0.010)以及TyG/HDL-C(OR=3.162,95%CI:1.228-8.141,P=0.017)与MAFLD独立相关。TyGBMI指数的ROC曲线下面积(AUC)为0.812,对MAFLD的敏感度为91.2%,特异度为69.2%。TyG/HDL-C指数的AUC为0.929,对MAFLD的敏感度为85.3%,特异度为88.5%。

结论

结果表明,TyG*BMI和TyG/HDL-C与非超重/肥胖T2DM患者的MAFLD独立相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b7e/10416783/569da282d957/DMSO-16-2345-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b7e/10416783/0177cd31bec2/DMSO-16-2345-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b7e/10416783/83846a3398ea/DMSO-16-2345-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b7e/10416783/569da282d957/DMSO-16-2345-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b7e/10416783/0177cd31bec2/DMSO-16-2345-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b7e/10416783/83846a3398ea/DMSO-16-2345-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b7e/10416783/569da282d957/DMSO-16-2345-g0003.jpg

相似文献

1
Non-Traditional Blood Lipid Indices for Metabolism Dysfunction-Associated Fatty Liver Disease Prediction in Non-Obese Type 2 Diabetes Mellitus.非传统血脂指标对非肥胖型2型糖尿病患者代谢功能障碍相关脂肪性肝病的预测价值
Diabetes Metab Syndr Obes. 2023 Aug 7;16:2345-2354. doi: 10.2147/DMSO.S418020. eCollection 2023.
2
Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study.甘油三酯-葡萄糖指数与甘油三酯/高密度脂蛋白胆固醇比值在代谢相关脂肪性肝病患者中的诊断价值比较:一项回顾性横断面研究。
Lipids Health Dis. 2022 Jun 25;21(1):55. doi: 10.1186/s12944-022-01661-7.
3
Biochemical and Anthropometric Indices of Insulin Resistance in Obese and Overweight Children with Metabolic Dysfunction-Associated Fatty Liver Disease.肥胖和超重伴代谢相关脂肪性肝病儿童的胰岛素抵抗的生化和人体测量学指标。
Med Sci Monit. 2024 Jul 3;30:e943375. doi: 10.12659/MSM.943375.
4
Associations Between GGT/HDL and MAFLD: A Cross-Sectional Study.γ-谷氨酰转肽酶与高密度脂蛋白比值和代谢功能障碍相关脂肪性肝病的关联:一项横断面研究。
Diabetes Metab Syndr Obes. 2022 Feb 9;15:383-394. doi: 10.2147/DMSO.S342505. eCollection 2022.
5
Utility of Indices Obtained during Medical Checkups for Predicting Fatty Liver Disease in Non-obese People.体检指标在预测非肥胖人群脂肪肝中的应用。
Intern Med. 2023 Aug 15;62(16):2307-2319. doi: 10.2169/internalmedicine.1097-22. Epub 2022 Dec 14.
6
Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Insulin Resistance-Related Indices in the Japanese Population.使用日本人群中与胰岛素抵抗相关的指标预测和验证代谢功能障碍相关的脂肪性肝病。
Metab Syndr Relat Disord. 2023 Nov;21(9):489-496. doi: 10.1089/met.2023.0116. Epub 2023 Oct 25.
7
Elevated small dense low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction associated fatty liver disease in Chinese patients with type 2 diabetes mellitus.小而密低密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值升高与中国 2 型糖尿病患者代谢功能障碍相关脂肪性肝病风险增加相关。
J Diabetes Investig. 2024 May;15(5):634-642. doi: 10.1111/jdi.14148. Epub 2024 Jan 22.
8
Value of the triglyceride-glucose index and non-traditional blood lipid parameters in predicting metabolic syndrome in women with polycystic ovary syndrome.三酰甘油-葡萄糖指数及非传统血脂参数在预测多囊卵巢综合征女性代谢综合征中的价值。
Hormones (Athens). 2023 Jun;22(2):263-271. doi: 10.1007/s42000-023-00438-6. Epub 2023 Feb 15.
9
Triglyceride glucose index is superior biomarker for predicting type 2 diabetes mellitus in children and adolescents.甘油三酯葡萄糖指数是预测儿童和青少年 2 型糖尿病的优秀生物标志物。
Endocr J. 2022 May 30;69(5):559-565. doi: 10.1507/endocrj.EJ21-0560. Epub 2021 Dec 17.
10
Modified triglyceride-glucose index indices are reliable markers for predicting risk of metabolic dysfunction-associated fatty liver disease: a cross-sectional study.改良的甘油三酯-葡萄糖指数是预测代谢功能障碍相关脂肪性肝病风险的可靠标志物:一项横断面研究。
Front Endocrinol (Lausanne). 2024 Jan 22;14:1308265. doi: 10.3389/fendo.2023.1308265. eCollection 2023.

引用本文的文献

1
Independent and combined associations of high-density lipoprotein cholesterol-modified triglyceride-glucose index with all-cause and cardiovascular mortality in patients with acute decompensated heart failure.急性失代偿性心力衰竭患者中高密度脂蛋白胆固醇修饰的甘油三酯-葡萄糖指数与全因死亡率和心血管死亡率的独立及联合关联
Front Endocrinol (Lausanne). 2025 Jul 29;16:1629066. doi: 10.3389/fendo.2025.1629066. eCollection 2025.
2
Association of triglyceride glucose-body mass index (TyG-BMI) with metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis.甘油三酯葡萄糖-体质指数(TyG-BMI)与代谢功能障碍相关脂肪性肝病的关联:一项系统评价和荟萃分析
PLoS One. 2025 Aug 4;20(8):e0324483. doi: 10.1371/journal.pone.0324483. eCollection 2025.

本文引用的文献

1
Unlocking the Full Potential of SGLT2 Inhibitors: Expanding Applications beyond Glycemic Control.解锁 SGLT2 抑制剂的全部潜力:超越血糖控制的应用拓展。
Int J Mol Sci. 2023 Mar 23;24(7):6039. doi: 10.3390/ijms24076039.
2
Screening for MAFLD: who, when and how?非酒精性脂肪性肝病(MAFLD)的筛查:对象、时机与方法?
Ther Adv Endocrinol Metab. 2023 Jan 21;14:20420188221145650. doi: 10.1177/20420188221145650. eCollection 2023.
3
Clinical spectrum transition and prediction model of nonalcoholic fatty liver disease in children with obesity.
儿童肥胖相关非酒精性脂肪性肝病的临床谱转换及预测模型。
Front Endocrinol (Lausanne). 2022 Aug 31;13:986841. doi: 10.3389/fendo.2022.986841. eCollection 2022.
4
Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes.三酰甘油葡萄糖指数联合体重指数对 2 型糖尿病患者非酒精性脂肪肝的诊断价值。
BMC Endocr Disord. 2022 Apr 15;22(1):101. doi: 10.1186/s12902-022-00993-w.
5
Global multi-stakeholder endorsement of the MAFLD definition.全球多方利益相关者对MAFLD定义的认可。
Lancet Gastroenterol Hepatol. 2022 May;7(5):388-390. doi: 10.1016/S2468-1253(22)00062-0. Epub 2022 Mar 3.
6
Associations Between GGT/HDL and MAFLD: A Cross-Sectional Study.γ-谷氨酰转肽酶与高密度脂蛋白比值和代谢功能障碍相关脂肪性肝病的关联:一项横断面研究。
Diabetes Metab Syndr Obes. 2022 Feb 9;15:383-394. doi: 10.2147/DMSO.S342505. eCollection 2022.
7
Prevalence and characteristics of MAFLD in Chinese adults aged 40 years or older: A community-based study.中国 40 岁及以上成年人 MAFLD 的患病率及特征:一项基于社区的研究。
Hepatobiliary Pancreat Dis Int. 2022 Apr;21(2):154-161. doi: 10.1016/j.hbpd.2022.01.006. Epub 2022 Jan 31.
8
Frequency of non-alcoholic fatty liver disease (NAFLD) and its associated risk factors among Type-2 diabetics.2型糖尿病患者中非酒精性脂肪性肝病(NAFLD)的发病率及其相关危险因素
Pak J Med Sci. 2022 Jan-Feb;38(1):28-33. doi: 10.12669/pjms.38.1.4968.
9
It Is High Time Physicians Thought of Natural Products for Alleviating NAFLD. Is There Sufficient Evidence to Use Them?是时候让医生考虑用天然产物来缓解非酒精性脂肪性肝病了。有足够的证据可以使用它们吗?
Int J Mol Sci. 2021 Dec 14;22(24):13424. doi: 10.3390/ijms222413424.
10
Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease.非酒精性脂肪性肝病的分子靶点及新兴药物治疗干预研究进展
Metabolism. 2022 Jan;126:154925. doi: 10.1016/j.metabol.2021.154925. Epub 2021 Nov 2.